Quarterly report · Q3

Period2022-06-01 → 2023-02-28
Filed2023-04-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥41.7bn2022-06-01 → 2023-02-28Cons.Net sales
Revenue¥55.1bn2021-06-01 → 2022-05-31Cons.Net sales (5-year summary)
Revenue¥40.6bn2021-06-01 → 2022-02-28Cons.Net sales
Operating income¥895m2022-06-01 → 2023-02-28Cons.Operating income
Operating income¥852m2021-06-01 → 2022-02-28Cons.Operating income
Ordinary income¥936m2022-06-01 → 2023-02-28Cons.Ordinary income
Ordinary income¥1.0bn2021-06-01 → 2022-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥907m2021-06-01 → 2022-02-28Cons.Ordinary income
Profit before tax¥333m2022-06-01 → 2023-02-28Cons.Income before income taxes
Profit before tax¥923m2021-06-01 → 2022-02-28Cons.Income before income taxes
Net income (owners)¥1m2022-06-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥696m2021-06-01 → 2022-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥592m2021-06-01 → 2022-02-28Cons.Profit loss attributable to owners of parent
Net income−¥3m2022-06-01 → 2023-02-28Cons.Profit loss
Net income¥591m2021-06-01 → 2022-02-28Cons.Profit loss
Total assets¥22.5bnat 2023-02-28Cons.Assets
Total assets¥24.1bnat 2022-05-31Cons.Assets
Total assets¥23.9bnat 2022-02-28Cons.Total assets (5-year summary)
Total liabilities¥14.8bnat 2023-02-28Cons.Liabilities
Total liabilities¥16.1bnat 2022-05-31Cons.Liabilities
Net assets / equity¥7.7bnat 2023-02-28Cons.Net assets
Net assets / equity¥8.0bnat 2022-05-31Cons.Net assets
Net assets / equity¥7.9bnat 2022-02-28Cons.Net assets (5-year summary)
Cash and deposits¥3.3bnat 2023-02-28Cons.Cash and deposits
Cash and deposits¥4.0bnat 2022-05-31Cons.Cash and deposits
EPS (basic)¥0.462022-06-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥79.442022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥272.672021-06-01 → 2022-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥232.032021-06-01 → 2022-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥47.212021-12-01 → 2022-02-28dCons.Basic earnings loss per share (5-year summary)
Equity ratio34.2%at 2023-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio33.1%at 2022-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio32.9%at 2022-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-06-01 → 2023-02-28−¥11m
Reconciling Itemsreconcilingrevenue intersegment2022-06-01 → 2023-02-28−¥11m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2023-02-28−¥690m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2022-06-01 → 2023-02-28¥211m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2022-06-01 → 2023-02-28¥211m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥0
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2022-06-01 → 2023-02-28¥10m
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue2022-06-01 → 2023-02-28¥41.5bn
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue external2022-06-01 → 2023-02-28¥41.5bn
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2022-06-01 → 2023-02-28¥11m
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentsegment profit2022-06-01 → 2023-02-28¥1.6bn
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentrevenue2022-06-01 → 2023-02-28¥50m
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentrevenue external2022-06-01 → 2023-02-28¥50m
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentsegment profit2022-06-01 → 2023-02-28¥0
—segment totalrevenue2022-06-01 → 2023-02-28¥41.7bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥41.7bn
—segment totalrevenue intersegment2022-06-01 → 2023-02-28¥11m
—segment totalsegment profit2022-06-01 → 2023-02-28¥1.6bn
Reconciling Itemsreconcilingrevenue2021-06-01 → 2022-02-28¥0
Reconciling Itemsreconcilingrevenue intersegment2021-06-01 → 2022-02-28¥0
Reconciling Itemsreconcilingsegment profit2021-06-01 → 2022-02-28−¥658m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue2021-06-01 → 2022-02-28¥214m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue external2021-06-01 → 2022-02-28¥214m
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentrevenue intersegment2021-06-01 → 2022-02-28¥0
jpcrp040300-q3r_E33393-000Medical Equipment Manufacturing And Salesreportable segmentsegment profit2021-06-01 → 2022-02-28¥12m
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue2021-06-01 → 2022-02-28¥40.4bn
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue external2021-06-01 → 2022-02-28¥40.4bn
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentrevenue intersegment2021-06-01 → 2022-02-28¥0
jpcrp040300-q3r_E33393-000Medical Equipment Salesreportable segmentsegment profit2021-06-01 → 2022-02-28¥1.5bn
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentrevenue2021-06-01 → 2022-02-28¥51m
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentrevenue external2021-06-01 → 2022-02-28¥51m
jpcrp040300-q3r_E33393-000Medical Mallreportable segmentsegment profit2021-06-01 → 2022-02-28−¥7m
—segment totalrevenue2021-06-01 → 2022-02-28¥40.6bn
—segment totalrevenue external2021-06-01 → 2022-02-28¥40.6bn
—segment totalrevenue intersegment2021-06-01 → 2022-02-28¥0
—segment totalsegment profit2021-06-01 → 2022-02-28¥1.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 360
ItemContextValueUnit
Cost of salesPrior1YTDDuration35149000000JPY
Cost of salesCurrentYTDDuration36017000000JPY
Gross profitPrior1YTDDuration5486000000JPY
Gross profitCurrentYTDDuration5708000000JPY
Selling general and administrative expensesPrior1YTDDuration4633000000JPY
Selling general and administrative expensesCurrentYTDDuration4813000000JPY
Operating incomePrior1YTDDuration852000000JPY
Operating incomeCurrentYTDDuration895000000JPY
Interest and dividends income noiPrior1YTDDuration7000000JPY
Interest and dividends income noiCurrentYTDDuration8000000JPY
Purchase discounts noiPrior1YTDDuration11000000JPY
Purchase discounts noiCurrentYTDDuration10000000JPY
Equity in earnings of affiliates noiPrior1YTDDuration10000000JPY
Equity in earnings of affiliates noiCurrentYTDDuration-JPY
Commission fee noiPrior1YTDDuration19000000JPY
Commission fee noiCurrentYTDDuration20000000JPY
Other noiPrior1YTDDuration13000000JPY
Other noiCurrentYTDDuration14000000JPY
Non operating incomePrior1YTDDuration62000000JPY
Non operating incomeCurrentYTDDuration55000000JPY
Interest expenses noePrior1YTDDuration2000000JPY
Interest expenses noeCurrentYTDDuration1000000JPY
Foreign exchange losses noePrior1YTDDuration-JPY
Foreign exchange losses noeCurrentYTDDuration1000000JPY
Loss on sales of notes payable noePrior1YTDDuration4000000JPY
Loss on sales of notes payable noeCurrentYTDDuration5000000JPY
Equity in losses of affiliates noePrior1YTDDuration-JPY
Equity in losses of affiliates noeCurrentYTDDuration3000000JPY
Other noePrior1YTDDuration1000000JPY
Other noeCurrentYTDDuration0JPY
Non operating expensesPrior1YTDDuration7000000JPY
Non operating expensesCurrentYTDDuration14000000JPY
Ordinary incomePrior1YTDDuration907000000JPY
Ordinary incomeCurrentYTDDuration936000000JPY
Receipts from contingent consideration eiPrior1YTDDuration11000000JPY
Receipts from contingent consideration eiCurrentYTDDuration6000000JPY
Gain on step acquisitions eiPrior1YTDDuration4000000JPY
Gain on step acquisitions eiCurrentYTDDuration-JPY
Gain on sales of investment securities eiPrior1YTDDuration-JPY
Gain on sales of investment securities eiCurrentYTDDuration1000000JPY
Extraordinary incomePrior1YTDDuration15000000JPY
Extraordinary incomeCurrentYTDDuration8000000JPY
Provision of allowance for doubtful accounts elPrior1YTDDuration-JPY
Provision of allowance for doubtful accounts elCurrentYTDDuration611000000JPY
Extraordinary lossPrior1YTDDuration-JPY
Extraordinary lossCurrentYTDDuration611000000JPY
Income before income taxesPrior1YTDDuration923000000JPY
Income before income taxesCurrentYTDDuration333000000JPY
Income taxes currentPrior1YTDDuration141000000JPY
Income taxes currentCurrentYTDDuration176000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-05-31pass
balance sheet identityconsolidated 2023-02-28pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-05-31pass
statement vs summary · net assetsconsolidated 2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2021-06-01/2022-02-28pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-02-28pass
statement vs summary · revenueconsolidated 2021-06-01/2022-02-28pass
statement vs summary · revenueconsolidated 2022-06-01/2023-02-28pass
statement vs summary · total assetsconsolidated 2022-05-31pass
statement vs summary · total assetsconsolidated 2023-02-28pass